Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 31 Jul 2020 |
10 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 24 Jul 2024 |
2 | Reply to Exam Report (MIS-R) | 03 Nov 2020 |
3 | Journal Copy | 12 Aug 2022 |
4 | TM-O(NOTICE OF OPPOSITION) | 21 Sep 2022 |
5 | TM-O(NOTICE OF OPPOSITION) | 17 Oct 2022 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 24 Nov 2023 |
7 | Annexure -1 under rule 46 | 24 Nov 2023 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 13 Apr 2024 |
9 | Annexure -1 under rule 46 | 13 Apr 2024 |
1 | EXAMINATION REPORT | 10331183 | 28 Aug 2020 | |
2 | Hearing Notice (Show Cause) | 12438400 | 09 Nov 2021 | |
3 | Hearing Notice (Show Cause) | 13338250 | 12 Apr 2022 | |
4 | Tribunal Accepted Notice for : 4592307 | 13631955 | 5629368 | 10 Jun 2022 |
5 | Opposition Notice | 15137081 | 5929360 | 24 Apr 2023 |
6 | Opposition Notice | 15208307 | 5944620 | 08 May 2023 |
7 | Opposition Counter Statement | 16806958 | 6387377 | 13 Dec 2023 |
As per IP India data the trademark was applied on 31 July 2020.
INTAS PHARMACEUTICALS applied for Fibrogen-i.
Listed class of trademark Fibrogen-i is 5.
Fibrogen-i is on the Opposed stage of the trademark process.
Serial Number provided to trademark application is 4592307
Trademark application was filed by the following attorney agent:
Y. J. Trivedi & Co
The trademark is categorized as DEVICE.